Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Neeraja Komanduri"'
Autor:
Sagar Narala, Neeraja Komanduri, Dinesh Nyavanandi, Ahmed Adel Ali Youssef, Preethi Mandati, Abdullah Alzahrani, Praveen Kolimi, Nagarjuna Narala, Michael A. Repka
Publikováno v:
Journal of Drug Delivery Science and Technology. 82:104384
Autor:
Suresh Bandari, Mashan Almutairi, Neeraja Komanduri, Feng Zhang, Michael A. Repka, Arun Butreddy
Publikováno v:
J Drug Deliv Sci Technol
Multicomponent crystalline solid forms (salts, cocrystals and eutectics) are a promising means of enhancing the dissolution behavior of poorly soluble drugs. The present study demonstrates the development of multicomponent solid forms of aripiprazole
Autor:
Soumyajit Majumdar, Siddharth K. Tripathi, Michael A. Repka, Narendar Dudhipala, Neeraja Komanduri, Ruchi Thakkar
Publikováno v:
International Journal of Pharmaceutics. 603:120676
The current study sought to formulate sustained-release hot-melt extruded (HME) ocular inserts of moxifloxacin hydrochloride (MOX; MOX-HME) for the treatment of bacterial keratitis. The concentration of Eudragit™ FS-100 (FS) and propylene glycol (P
Autor:
Rui Wang, Arun Kumar Kotha, Subhas Balaram Bhowmick, Mahavir B. Chougule, Neeraja Komanduri, Saikat Ghosh
Publikováno v:
Novel Drug Delivery Technologies ISBN: 9789811336416
The barriers in the delivery of the therapeutic agent to brain diseases are blood–brain barrier (BBB), blood-cerebrospinal fluid barrier, and cellular barriers. The above mentioned barriers limit the distribution of the therapeutic agent or drug de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2cefad269f11432123b1e902d205c38
https://doi.org/10.1007/978-981-13-3642-3_11
https://doi.org/10.1007/978-981-13-3642-3_11
Autor:
Suresh Bandari, Arun Butreddy, Nagireddy Dumpa, Neeraja Komanduri, Michael A. Repka, Honghe Wang
Publikováno v:
Int J Pharm
Advancements in pharmaceutical technologies have led to the personalization of therapies over the last decade. Three-dimensional printing (3DP) is an emerging technique in the manufacturing of pharmaceutical dosage forms because of its potential to c
Autor:
Himanshu Bhatt, Sri Vishnu Kiran Rompicharla, Sateja Paradkar, Shah Aashma, Neeraja Komanduri, Swati Biswas, Balaram Ghosh
Publikováno v:
Current drug delivery. 15(9)
Background Solid lipid nanoparticles (SLNs) represent an affordable, easily scalable, stable and biocompatible drug delivery system with a high drug to lipid ratio which also improves solubility of poorly soluble drugs. Objective SLNs were developed
Autor:
Neeraja Komanduri, Himanshu Bhatt, Aashma Shah, Sri Vishnu Kiran Rompicharla, Dhanya Vijayasarathy, Balaram Ghosh, Swati Biswas
Publikováno v:
Chemistry and physics of lipids. 208
The aim of the present research was to develop a novel, biocompatible, amenable to industrial scale up and affordable solid lipid nanoparticles (SLN) preparation of curcumin and evaluate the therapeutic efficacy in vitro using cancer cells. We have i